Kellogg School

Schulte Roth & Zabel Adds Two Key Business Leaders

Retrieved on: 
水曜日, 7月 19, 2023
Human resources, Corporate Affairs, IPO, Yale College, University, Goldman, AB InBev, Culture, Communication studies, AB, Lead, EmblemHealth, Spotify, Lawyer, Kellogg School, Manhattan Chamber of Commerce, Practice, The Interpublic Group of Companies, GHI, Goldman Sachs, HIP, Acquisition, The Walt Disney Company, Citigroup, DEI, Growth, Avon Products, Manhattan, Schulte Roth & Zabel, SA, Courage, Northwestern University, Commerce, Columbia Law School, Management, Industrial design, Grupo Financiero Banamex

"Talent and innovation drive our business, so we are very excited to bring on board leaders like Jean and John," said Marc Elovitz, co-managing partner of Schulte.

Key Points: 
  • "Talent and innovation drive our business, so we are very excited to bring on board leaders like Jean and John," said Marc Elovitz, co-managing partner of Schulte.
  • He will collaborate with lawyers and business professionals across the firm to develop, lead and execute on the firm's innovation strategy.
  • "Schulte has a reputation for exceptional client service and I'm excited to support employees' professional goals and advance the firm's business objectives."
  • Jean spent more than 25 years working across a multitude of industries to ensure that people strategies reflect and enable key business initiatives.

Pattern Appoints Carolyn Sarnoff as Chief Marketing Officer

Retrieved on: 
水曜日, 7月 19, 2023
Software, Online Retail, Internet, Search Engine Marketing, Electronic Commerce, Technology, Artificial Intelligence, Digital Marketing, Retail, Marketing, Advertising, Communications, Psychology, University, SVKM's NMIMS, Berkeley, Multimedia, Kellogg School, CMO, History, Amazon, Business administration, Sarnoff, Acquisition, GM, Growth, Master of Business Administration, Salesforce, PR, Management, Online shopping, Pattern

Pattern , the category leader for global ecommerce acceleration, today announced the addition of former Amazon executive Carolyn Sarnoff as chief marketing officer.

Key Points: 
  • Pattern , the category leader for global ecommerce acceleration, today announced the addition of former Amazon executive Carolyn Sarnoff as chief marketing officer.
  • View the full release here: https://www.businesswire.com/news/home/20230719131967/en/
    Trailblazing former Amazon executive Carolyn Sarnoff brings nearly 20 years of experience driving global ecommerce growth and innovation to her new role as CMO at Pattern.
  • (Photo: Business Wire)
    Sarnoff brings nearly 20 years of experience building and leading global ecommerce businesses and marketing functions to her new role at Pattern.
  • Sarnoff received a Master of Business Administration from the Kellogg School of Management, with concentrations in marketing and strategy.

Beam Suntory Announces CEO Transition

Retrieved on: 
火曜日, 7月 18, 2023
Retail, Restaurant, Bar, Other Retail, Wine & Spirits, Heart, University, Senior, Kraft Foods, Marketing, Culture, Baladi, Senior advisor, Business, Hughes, Suntory, Procter, MBA, COVID, Kellogg School, Beam, Procter & Gamble, GM, Beam Suntory, Humble Oil, Growth, Family, Northwestern University, Management

Beam Suntory President & CEO Albert Baladi today announced that he will transition CEO responsibilities effective October 1, 2023, to Greg Hughes, the company’s current Senior Vice President Chief Growth & Brands Officer.

Key Points: 
  • Beam Suntory President & CEO Albert Baladi today announced that he will transition CEO responsibilities effective October 1, 2023, to Greg Hughes, the company’s current Senior Vice President Chief Growth & Brands Officer.
  • Baladi has served on the executive leadership team of Beam Suntory for 12 years, including the past five years as President & CEO.
  • Since he stepped into the CEO role in 2019, Beam Suntory’s annual sales have grown at high single digits to more than $5 billion.
  • I am very proud of what we have built these past 12 years and am grateful for the opportunity to lead Beam Suntory as President & CEO during a five-year period of massive transformation for our company.”
    “On behalf of Suntory Holdings, I’d like to express deep appreciation to Albert for his tremendous leadership, exemplary contributions, and impact during his 12-year tenure with Beam Suntory,” said Tak Niinami, President & CEO of Suntory Holdings.

Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer

Retrieved on: 
月曜日, 7月 17, 2023
Fulcrum, Acorda Therapeutics, University, Therapy, Cancer, MBA, Kellogg School, AMPS, Sutro Biopharma, Chiesi Farmaceutici, Metabolism, Civitas, Champaign–Urbana metropolitan area, Medicine, Drug discovery, Northwestern University, Ovation Pharmaceuticals, Management, Fine chemical

Mr. Stuart will succeed Jeff Goater, a venture partner at The Column Group, who has served as interim CEO of Atavistik Bio since January 2022 and will continue to serve as a Director on Atavistik Bio’s Board.

Key Points: 
  • Mr. Stuart will succeed Jeff Goater, a venture partner at The Column Group, who has served as interim CEO of Atavistik Bio since January 2022 and will continue to serve as a Director on Atavistik Bio’s Board.
  • “We are delighted to welcome Bryan as CEO to steer the exciting growth ahead for Atavistik Bio,” said Dr. John Josey, Atavistik Bio’s Board Chair.
  • “I’m proud of the remarkable progress that the Atavistik Bio team has made in such a short period,” said Mr. Goater.
  • I look forward to working with Bryan, the Atavistik Bio team, and my fellow Board members as the Atavistik Bio story continues to unfold.”

Summit Park Welcomes New Members to LEAD Program

Retrieved on: 
火曜日, 7月 11, 2023
Asset Management, Professional Services, Finance, Aurora, Columbia University, United States service academies, Freedom, Marine Corps Expeditionary Medal, McCombs School of Business, United States Department of the Army, BS, University, Dell, Moses Austin, Combat Aviation Brigade, 101st Airborne Division, Environmental science, UVA, Elliott Aviation, Consultant, Faculty of Political Science and International Relations, Matej Bel University, University of Texas at Austin, Jack Hawkins (U.S. Marine Corps officer), Business, Airborne forces, Aurora Innovation, Record, Electronics, Delta Air Lines, Parimutuel betting, MBA, Kellogg School, University of Virginia Darden School of Business, Associate, Infantry, USS, Summit Park, Utah, Growth, GTM, Dell Technologies, Summit, Northwestern University, Accenture, Management, Entrepreneurship

The LEAD program develops execution-focused and operationally talented executives who assume a meaningful and mission critical role as Chief of Staff at businesses within Summit Park’s portfolio.

Key Points: 
  • The LEAD program develops execution-focused and operationally talented executives who assume a meaningful and mission critical role as Chief of Staff at businesses within Summit Park’s portfolio.
  • LEAD executives actively participate in the leadership of the day-to-day operations of the business and assist in the creation and execution of company-wide long-term strategy.
  • Prior to Delta Air Lines, Fletcher served as an infantry officer in the U.S. Marines for six years.
  • Prior to joining the LEAD program, Dan was an Operations Manager at Aurora Innovation, a self-driving vehicle technology company.

Replicate Bioscience Appoints Rachael Lester as Chief Business Officer

Retrieved on: 
月曜日, 7月 10, 2023
Amgen, Business development, University, SVKM's NMIMS, Therapy, Senior, Marketing, Diluted property rights theory, Roche, Infection, University of Pennsylvania, Kellogg School, RNA, Onyx Pharmaceuticals, Harpoon, Product marketing, Strategic management, Neuroscience, Acquisition, Patient, AbbVie, SAN, Autoimmune disease, Growth, Northwestern University, Replicate, Management, Pharmaceutical industry, Carfilzomib, Onyx, Arbutus Biopharma

SAN DIEGO, July 10, 2023 /PRNewswire/ -- Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, announced today that it has appointed Rachael Lester as its Chief Business Officer. Ms. Lester, who has more than 20 years of experience as a senior executive in the biopharmaceutical industry, will be responsible for leading corporate strategy, business development, portfolio strategy, and new product planning.

Key Points: 
  • Biopharma executive with more than 20 years of global corporate, business development, and commercial strategy experience to join Replicate leadership team
    SAN DIEGO, July 10, 2023 /PRNewswire/ -- Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, announced today that it has appointed Rachael Lester as its Chief Business Officer.
  • "I am delighted to welcome Rachael to the Replicate leadership team.
  • Rachael has demonstrated an ability to drive growth and value at leading companies in our sector," said Nathaniel Wang, Ph.D., Chief Executive Officer at Replicate.
  • Ms. Lester joins Replicate from Harpoon Therapeutics (NASDAQ: HARP), a clinical-stage immunotherapy company, where she most recently served as Senior Vice President, Business Development and Corporate Strategy.

Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer

Retrieved on: 
月曜日, 7月 10, 2023
Epilepsy, United States Navy, Medicine, University, Marketing, Chief commercial officer, Clinical trial, MBA, Brain, Kellogg School, Economics, Thought, Dasyphyllum diacanthoides, Organization, Route, Thrombectomy, Patient, SAN, Health, Growth, Northwestern University, LivaNova, Eastern Coast of Central America Commercial and Agricultural Company, Stroke

SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Chris Hartman to the role of Chief Commercial Officer.

Key Points: 
  • SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Chris Hartman to the role of Chief Commercial Officer.
  • In this role, Chris will be responsible for continuing to build the sales and marketing organizations to grow Route 92 Medical’s global commercial footprint.
  • “Route 92 Medical has developed remarkable technologies which offer the potential to dramatically improve outcomes for patients who have endovascular procedures in the brain, starting with a game-changing therapy for ischemic stroke,” said Chris Hartman, Chief Commercial Officer at Route 92 Medical.
  • “Chris has been remarkably successful in facilitating commercial growth in the neurovascular space and other medical technology categories,” said Tony Chou, CEO of Route 92 Medical.

Charles River Associates (CRA) Expands Its Life Sciences Practice

Retrieved on: 
木曜日, 7月 6, 2023
Biotechnology, Consulting, Health, Professional Services, Legal, Ophthalmology, Marketing, Management, San Francisco Bay Area, CRAI, SVKM's NMIMS, CRA International, MBA, Ng, Cornell University, Kellogg School, Strategic planning, CRA

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services , today announced that Sheldon Ng has joined the company’s Life Sciences Practice as a vice president.

Key Points: 
  • Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services , today announced that Sheldon Ng has joined the company’s Life Sciences Practice as a vice president.
  • Prior to joining CRA, Ng was a partner with a number of different life sciences strategy consulting firms in the San Francisco Bay Area.
  • Ng launched and led strategy and business analytics practices specializing in the life sciences industry’s most critical issues.
  • Ng has an MBA in marketing and health care enterprise management from the Kellogg School of Management and a BA in biological sciences from Cornell University.

L'OREAL NAMES LILIAHN MAJEED AS CHIEF DIVERSITY, EQUITY & INCLUSION OFFICER, NORTH AMERICA

Retrieved on: 
火曜日, 6月 27, 2023
WNBA, Season, WNBA Social Justice Council, SVKM's NMIMS, Social justice, Howard University, Walt Disney World, Culture, NBA scoring leaders, National Basketball Association, Billie Jean King Leadership Initiative, Kellogg School, Movement, 1978 Davis Cup Americas Zone, Universal Music Group, Creativity, Margaret, NBA G League, Organization, DE, Task force, Beauty, World Leadership Forum, NBA, Diversity, UMG, Northwestern University, Four Seasons Hotels and Resorts, Management, Equity, Woman

NEW YORK, June 27, 2023 /PRNewswire/ -- L'Oréal today announced the appointment of Liliahn Majeed as Chief Diversity, Equity, and Inclusion Officer, North America.

Key Points: 
  • NEW YORK, June 27, 2023 /PRNewswire/ -- L'Oréal today announced the appointment of Liliahn Majeed as Chief Diversity, Equity, and Inclusion Officer, North America.
  • In this role, Majeed will report to David Greenberg, CEO, L'Oréal USA and President, North America Zone.
  • She will join the management committee of L'Oréal USA as well as the leadership team of Margaret Johnston-Clarke, L'Oréal's global Diversity, Equity, and Inclusion Officer.
  • Majeed moves into the Chief Diversity, Equity, and Inclusion Officer, North America role which was previously held by Angela Guy who has decided to retire from L'Oréal after a distinguished and award-winning 19-year career with the company.

Velsera Announces Appointment of Two New Board Members

Retrieved on: 
火曜日, 6月 27, 2023
Biotechnology, Technology, Managed Care, Health, Pharmaceutical, Oncology, Health Technology, Research, Software, Science, Clinical Trials, Molecular biology, Amgen, Human, University, SVKM's NMIMS, Biochemistry, Marketing, Brake, Quality of life, Coty, MBA, Medicine, Kellogg School, Doctor of Philosophy, Organization, MAC, Takeda Oncology, Patient, Love, MAC Cosmetics, Northwestern University, Nursing, Management, Unilever

“I find what Velsera is doing -- to power precision oncology to marry the medicine to the patient -- very inspiring,” Brake said. “Given my professional background working across discovery research, clinical development and medical affairs, I understand where the roadblocks to this vision might be. I look forward to helping to develop strategies to define where Velsera can bring value to these kinds of customers and the patients they serve.”

Key Points: 
  • Velsera , a healthcare technology company offering a universal software platform to connect clinical care with discovery, today announced the addition of Rachael Brake, PhD, and Ukonwa Ojo to its board of directors.
  • Brake is a distinguished scientist with more than 20 years of experience in R&D, global clinical development and medical affairs.
  • She serves as the chief scientific officer of Corbus Pharmaceuticals, a precision oncology company, and prior to that she worked in leading roles at Takeda Oncology and Amgen.
  • “I find what Velsera is doing -- to power precision oncology to marry the medicine to the patient -- very inspiring,” Brake said.